The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Parafend Plus Oral Suspension

25/50 milligram(s)/millilitre Oral suspension

Norbrook Laboratories (Ireland) LimitedVPA22664/070/001

Main Information

Trade NameParafend Plus Oral Suspension
Active SubstancesOxfendazole
Closantel
Strength25/50 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/070/001

Group Information

ATC CodeQP52AC52 oxfendazole, combinations
Therapeutic ClassEndoparasiticide
SpeciesSheep

Status

Authorised/WithdrawnAuthorised
Licence Issued30/06/2003
Legal StatusLM: Licensed Merchant as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back